Thus, the ultimate aim of our research was to investigate if the amount of adipose tissue, skeletal muscle mass, obesity and sarcopenia are predictive of a positive or negative prognosis in metastatic ER+/HER2- BC patients. Here, ERBB2 is linked to breast cancer.